IGFBP4 anticorps (N-Term)
Aperçu rapide pour IGFBP4 anticorps (N-Term) (ABIN453124)
Antigène
Voir toutes IGFBP4 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Specificité
- This antibody recognizes IGFBP4 (N-term).
-
Réactivité croisée (Details)
- Species reactivity (tested):Human and Mouse.
-
Purification
- Affinity Chromatography on Protein A
-
Immunogène
- KLH conjugated synthetic peptide selected from the N-terminal region of Human IGFBP4.
-
-
-
-
Indications d'application
-
ELISA: 1/1,000. Western blotting: 1/100-1/500.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.25 mg/mL
-
Buffer
- PBS with 0.09 % (W/V) Sodium Azide as preservative
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- Avoid repeated freezing and thawing.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- IGFBP4 (Insulin-Like Growth Factor Binding Protein 4 (IGFBP4))
-
Autre désignation
- IGFBP4
-
Sujet
- IGFBP4 has an IGFBP domain and a thyroglobulin type-I domain. The protein binds both insulin-like growth factors (IGFs) I and II and circulates in the plasma in both glycosylated and non-glycosylated forms. Binding of this protein prolongs the half-life of the IGFs and alters their interaction with cell surface receptors.Synonyms: IBP-4, IBP4, IGF-binding protein 4, IGFBP-4, Insulin-like growth factor-binding protein 4
-
Poids moléculaire
- 27934 Da
-
ID gène
- 3487
-
NCBI Accession
- NP_001543
-
UniProt
- P22692
-
Pathways
- Signalisation WNT, Myometrial Relaxation and Contraction, Regulation of Carbohydrate Metabolic Process
Antigène
-